Pharmaceuticals

Gene Silencing Market Size and Demand Forecast 2026–2030

February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gene silencing market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Gene Silencing Market in 2030?

The gene silencing market has experienced significant expansion in recent times. Projections indicate its value will increase from $6.69 billion in 2025 to $7.53 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. Historically, this growth can be attributed to several factors, including progress in molecular biology research, the identification of RNA interference mechanisms, increased funding for academic research, a rise in studies related to genetic diseases, and enhanced spending on pharmaceutical R&D.

The gene silencing market is poised for significant expansion over the next few years. Its valuation is projected to reach $12.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period can be attributed to factors such as growth of gene therapy pipelines, rising demand for targeted therapeutics, expansion of crispr applications, increased clinical trial activity, and development of next-generation gene editing tools. Key trends expected in this period include growing adoption of rna interference technologies, increasing use of crispr-based gene silencing, expansion of therapeutic gene targeting, rising focus on precision medicine applications, and increasing investment in genetic research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp

What Drivers Are Influencing Production Trends In The Gene Silencing Market?

An increase in the occurrence of genetic disorders is projected to propel the growth of the gene silencing market in the future. These are medical conditions stemming from abnormalities in an individual’s DNA. Their identification is becoming more frequent due to advancements in diagnostic technologies, heightened awareness, and broader access to genetic testing. The rise in genetic disorders is also linked to increasing parental age, which elevates the risk of genetic mutations being passed to offspring. Gene silencing presents a promising approach to treating genetic disorders by selectively shutting down the expression of faulty or disease-causing genes. For example, in August 2023, according to Down Syndrome UK, a UK-based charity, Down syndrome affects an estimated 40,000 people in the UK, with approximately 1 in every 800 babies born with the condition. Therefore, the growing prevalence of genetic disorders is a key driver for the gene silencing market’s expansion.

Which Segments Are Gaining Traction In The Gene Silencing Market?

The gene silencing market covered in this report is segmented –

1) By Type: Transcriptional, Post-Transcriptional, Meiotic

2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings

3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications

4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users

Subsegments:

1) By Transcriptional: DNA Methylation, Histone Modification

2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing

3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

What Upcoming Trends Are Likely To Define The Future Path Of The Gene Silencing Market?

Leading companies in the gene silencing market are prioritizing the creation of advanced technologies, such as small interfering RNA (siRNA), to improve the precision and effectiveness of gene therapy. Small interfering RNA (siRNA) is an RNA molecule that plays a vital role in the RNA interference (RNAi) pathway by attaching to specific messenger RNA (mRNA) and prompting its degradation, thereby preventing the creation of disease-causing proteins. For example, in October 2024, Judo Bio Inc., a US-based biotechnology company, unveiled siRNA, a next-generation drug that utilizes small interfering RNA (siRNA) to silence genes. Its distinctive attributes include proprietary delivery systems, such as lipid nanoparticles or conjugated ligands, which ensure efficient uptake by specific cells or tissues, and AI-driven platforms that accelerate the identification of viable gene targets.

Who Are The Core Companies Influencing Trends In The Gene Silencing Market?

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

Which Regions Are Projected To Dominate The Gene Silencing Market In The Coming Years?

North America was the largest region in the gene silencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gene Silencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp

Browse Through More Reports Similar to the Global Gene Silencing Market 2026, By The Business Research Company

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795